Histamine deficiency in gene-targeted mice strongly reduces antigen-induced airway hyper-responsiveness, eosinophilia and allergen-specific IgE

International Immunology

Volumn 15, Issue 8, 2003, Pages 963-973

  Kozma, Gergely T ^a   Losonczy, György ^b   Keszei, Márton ^a   Komlósi, Zsolt ^b   Buzás, Edit ^a   Pállinger, Éva ^b   Appel, Judith ^b   Szabó, Teréz ^c   Magyar, Pál ^b   Falus, András ^a,b   Szalai, Csaba ^b,c  

^a SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^b SEMMELWEIS UNIVERSITY   (Hungary)

^c HEIM PÁL CHILDREN S HOSPITAL   (Hungary)

Author keywords

Chemokine; Inflammation; Knockout; Mast cell; Th1 Th2 cell

Indexed keywords

ALLERGEN; ANTIGEN; CHEMOKINE; CYTOKINE; GAMMA INTERFERON; HISTAMINE; HISTIDINE DECARBOXYLASE; IMMUNOGLOBULIN E; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; OVALBUMIN;

ALLERGIC ASTHMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRONCHUS HYPERREACTIVITY; CONTROLLED STUDY; CYTOKINE RELEASE; EOSINOPHILIA; GENE TARGETING; IMMUNE RESPONSE; INFLAMMATION; KNOCKOUT MOUSE; LUNG LAVAGE; MAST CELL DEGRANULATION; MEDIATOR RELEASE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROVOCATION TEST; SENSITIZATION; TH1 CELL; TH2 CELL; WILD TYPE;

ANALYSIS OF VARIANCE; ANIMALS; ASTHMA; BRONCHIAL PROVOCATION TESTS; BRONCHOALVEOLAR LAVAGE FLUID; CHEMOKINES; CYTOKINES; DATA INTERPRETATION, STATISTICAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; EOSINOPHILIA; EOSINOPHILS; FEMALE; GENE EXPRESSION PROFILING; HISTAMINE; HISTIDINE DECARBOXYLASE; HISTOCYTOCHEMISTRY; IMMUNIZATION; IMMUNOGLOBULIN E; INTERFERON TYPE II; INTERLEUKIN-4; LEUKOCYTE COUNT; LUNG; METHACHOLINE CHLORIDE; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; NEUTROPHILS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OVALBUMIN; PLETHYSMOGRAPHY;

EID: 12444262284     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/dxg095     Document Type: Article

References (45)

1. Gleich, G. 1990. The eosinophilic and bronchial asthma. Current understanding. J. Allergy Clin. Immunol. 140:1500.
2. Hart, P. H. 2001. Regulation of the inflammatory response in asthma by mast cell products. Immunol. Cell. Biol. 79:149.
3. Assanasen, P. and Naclerio, R, M. 2002. Antiallergic anti-inflammatory effects of H1-antihistamines in humans. Clin. Allergy Immunol. 17: 101.
4. Simons, F. E. 1999. Is antihistamine (H1-receptor antagonist) therapy useful in clinical asthma? Clin. Exp. Allergy Suppl. 3:98.
5. Geha, R. S. and Meltzer, E. O. 2001. Desloratadine: a new, nonsedating, oral antihistamine. J. Allergy Clin. Immunol. 107:751.
6. Hill, S. J. 1990. Distribution, properties, and functional characteristics of three classes of histamine receptor. Pharmacol. Rev. 42:45.
7. Watanabe, T., Yamatodani, A., Maeyama, K. and Wada, H. 1990. Pharmacology of alpha-fluoromethylhistidine, a specific inhibitor of histidine decarboxylase. Trends Pharmacol. Sci. 11:363.
8. László V. and Falus, A. 2000. Yet unrevealed aspects of histamine: questions from outside - answers at inside? Semin. Cancer Biol. 10:1.
9. Liu, C., Ma, X., Jiang, X., Wilson, S. J., Hofstra, C. L., Blevitt, J., Pyati, J., Li, X., Chai, W., Carruthers, N. W. and Lovenberg, T. 2001. Cloning and pharmacological characterization of a fourth histamine receptor (H(4)) expressed in bone marrow. Mol. Pharmacol. 59:420.
10. Leurs, R., Smit, M. J. and Timmerman, H. 1995. Molecular pharmacological aspects of histamine receptors. Pharmacol. Ther. 66:413.
11. Ohtsu, H., Tanaka, S., Terui, T., Hori, Y., Makabe-Kobayashi, Y., Pejler, G., Tchougounova, E., Hellman, L., Gertsenstein, M., Hirasawaf, N., et al. 2001. Mice lacking histidine decarboxylase exhibit abnormal mast cells. FEBS Lett. 502:53.
12. Cieslewicz, G., Tomkinson, A., Adler, A., Duez, C., Schwarze, J., Takeda, K., Larson, K. A., Lee, J. J., Irvin, C. G. and Gelfand, E. W. 1999. The late, but not early, asthmatic response is dependent on IL-5 and correlates with eosinophil infiltration. J. Clin. Invest. 104:301.
13. Hamelmann E., Schwarze, J., Takeda, K., Oshiba, A., Larsen, G. L., Irvin, C. G. and Gelfand, E. W. 1997. Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography. Am. J. Respir. Crit. Care Med. 156:766.
14. Hori, Y., Nihei, Y., Kurokawa, Y., Kuramasu, A., Makabe-Kobayashi, Y., Terui, T., Doi, H., Satomi, S., Sakurai, E., Nagy, A., Watanabe, T. and Ohtsu, H. 2002. Accelerated clearance of Escherichia coli in experimental peritonitis of histamine-deficient mice. J. Immunol. 169:1978.
15. Qiu, B., Frait, K. A., Reich, F., Komuniecki, E and Chensue, S. W. 2001. Chemokine expression dynamics in mycobacterial (type-1) and Schistosomal (type-2) antigen-elicited pulmonary granuloma formation. Am. J. Pathol. 158:1503.
16. Wasserman, S. I. 1983. Mediators of immediate-hypersensitivity. J. Allergy Clin. Immunol. 72:101.
17. Igaz P., Novák, I., Lázár, E., Horváth, B., Héninger, E. and Falus. A. 2001. Bidirectional communication between histamine and cytokines. Inflam. Res. 50:123.
18. Horváth B., V., Szalai, C., Mándi, Y., László, V., Radvány, Y., Darvas, Z. and Falus, A. 1999. Histamine and histamine-receptor antagonists modify gene expression and biosynthesis of interferon γ in peripheral human blood mononuclear cells and in CD19 depleted cell subsets. Immunol. Lett. 70:95.
19. Mazzoni, A., Young. A. Y., Spitzer, J. H., Visinten, A. and Segal, D. M. 2001. Histamine regulates cytokine production in maturing dendritic cells, resulting in altered T cell polarization. J. Clin. Invest. 108:1865.
20. Fujikura, T., Shimosawa, T. and Yakuo, I. 2001. Regulatory effect of histamine H1 receptor antagonist on the expression of messenger RNA encoding CC chemokines in the human nasal mucosa. J. Allergy Clin. Immunol. 107:123.
21. Wiener, Z., Andrásfalvy, M., Pállinger, É., Kovács, P., Szalai, C., Erdei. A., Tóth, S., Nagy, A. and Falus, A. 2002. Bone marrow-derived mast cell differentiation is strongly reduced in histidine decarboxylase knockout, histamine-free mice. Int. Immunol. 14:381.
22. William, C. M. M. and Galli, S. J. 2000. Mast cells can amplify airway reactivity and features of chronic inflammation in an asthma model in mice. J. Exp. Med. 192:455.
23. Takeda, K., Hamelmann, E., Joetham, A., Schultz, L. D., Larsen, G. L., Irvin, C. G. and Gelfand, E. W. 1997. Development of eosinophilic airway inflammation and airway hyperresponsiveness in mast cell-deficient mice. J. Exp. Med. 18:449.
24. Drazen, J. M., Arm, J. P. and Austen, K. F. 1996. Sorting out the cytokines of asthma. J. Exp. Med. 183:1.
25. Leong, K. P. and Huston, D. P. 2001. Understanding the pathogenesis of allergic asthma using mouse models. Ann. Allergy Asthma Immunol. 87:96.
26. Hamelmann, E., Tadeda, K., Oshiba, A. and Gelfand, E. W. 1999. Role of IgE in the development of allergic airway inflammation and airway hyperresponsiveness - a murine model. Allergy. 54:297.
27. h2 cytokines in the development of allergen-induced airway inflammation and hyperresponsiveness. Int. Arch. Allergy Immunol. 118:90.
28. Horvath B. V., Falus, A., Toth, S., Szalai, C., Lazar-Molnar, E., Holub, M. C., Buzas, E., Nagy, A. and Fulop, A. K. 2002. Inverse regulation of interleukin-6 (IL-6) and IL-6 receptor in histamine deficient histidine decarboxylase-knock-out mice. Immunol. Lett. 80:151.
29. Denzler, K. L., Farmer, S. C., Crosby, J. R., Borchers, M., Cieslewicz, G., Larson, K. A., Cormier-Regard, S., Lee, N. A. and Lee, J. J. 2000. Eosinophil Major Basic Protein-1 does not contribute to allergen-induced airway pathologies in mouse models of asthma. J. Immunol. 165:5509.
30. Mattes, J., Yang, M., Mahalingam, S., Kuehr, J., Webb, D. C., Simson, S. P., Koskinen, A., McKenzie, A. N. J., Dent, L. A., Rothenberg, M. E., Matthaei, K. I., Young, G. I. and Foster, P. S. 2002. Intrinsic defect in T cell production of interleukin (IL)-13 in the absence of both IL-5 and eotaxin precludes the development of eosinophilia and airway hyperreactivity in experimental asthma. J. Exp. Med. 195:1433.
31. Hamelmann, E., Oshiba, A., Loader, J., Larsen, G. L., Gleich, G., Lee, J. and Gefand, E. W. 1997. Antiinterleukin-5 antibody prevents airway hyperresponsiveness in a murine model of airway sensitization. Am. J. Respir. Crit. Care Med. 155:819.
32. Kubes, P. and Kanwar, S. 1994. Histamine induces leukocyte rolling in post-capillary venules: a P-selectin-mediated event. J. Immunol. 152:3570.
33. De Sanctis, G. T., Wolyniec, W. W., Green, F. H., Qin, S., Jiao, A., Finn, P, W., Noonan, T., Joetham, A, A. and Gelfand, E. 1997. Reduction of allergic airway responses in P-selectin-deficient mice. J. Appl. Physiol. 83:81.
34. Koarai, A., Ichinose, M., Ishigaki-Suzuki, S., Yamagata, S., Sugiura, H., Sakurai, E., Makabe-Kobayashi, Y., Kuramasu, A., Watanabe, T., Shirato, K., Hattori, T. and Ohtsu, H. 2003. Disruption of L-histidine decarboxylase reduces airway eosinophilia but not hyperresponsiveness. Am. J. Respir. Crit. Care Med. 167:758.
35. Fiorentino, D., Zlotnik, A., Mosmann, T. R., Howard, M. and O'Garra, A. 1991. IL-10 inhibits cytokine production by activated macrophages. J. Immunol. 147:3815.
36. + T lymphocyte and eosinophil infiltration into the mouse peritoneal cavity. J. Immunol. 57:377.
37. Hamelmann, E. and Gelfand, E. W. 2001. IL-5-induced airway eosinophilia - the key to asthma? Immunol. Rev. 179:182.
38. Park, M., Hoffmann, K. F., Cheever, A. W., Amichay, D., Wynn, T. A. and Farber, J. M. 2001. Patterns of chemokines expression in models of Schistosoma mansoni inflammation and infection reveal relationship between type 1 and type 2 responses and chemokines in vivo. Infect. Immun. 69:6755.
39. Campbell, J. J., Hedrick, J., Zlotnik, A., Siani, M. A., Thompson, D. A. and Butcher, E. C. 1998. Chemokines and the arrest of lymphocytes rolling under flow condition. Science. 279:381.
40. Scheuerer, B., Ernst, M., Durrbaum-Landmann, I., Fleischer, J., Grage-Griebenow, E., Brandt, E., Flad, H. D. and Petersen, F. 2000. The CXC-chemokine platelet factor 4 promotes monocyte survival and induces monocyte differentiation into macrophages. Blood 95:1158.
41. Bochner, B. S. 2000. Systemic activation of basophils and eosinophils: markers and consequences. J. Allergy Clin. Immunol. 106:S292.
42. Dunzendorfer, S., Kaneider, N. C., Kaser, A., Woell, E., Frade, J. M., Mellado, M., Martinez-Alonso, C. and Wiedermann, C. J. 2001. Functional expression of chemokine receptor 2 by normal human eosinophils. J. Allergy Clin. Immunol. 108:581.
43. Szalai, C., Kozma, G. T., Nagy, A., Bojszkó, A., Krikovszky, D., Szabó, T. and Falus, A. 2001. Polymorphism in the gene regulatory region of MCP-1 is associated with asthma susceptibility and severity. J. Allergy Clin. Immunol. 108:375.
44. Gangur, V. and Oppenheim, J. J. 2000. Are chemokines essential or secondary participants in allergic responses? Ann. Allergy Asthma Immunol. 84:569.
45. Medoff, B. D., Sauty, A., Tager, A. M., Maclean, J. A., Smith, R. N., Mathew, A., Dufour, J. H. and Luster, A. D. 2002. IFN-gamma-inducible protein 10 (CXCL10) contributes to airway hyperreactivity and airway inflammation in a mouse model of asthma. J. Immunol. 168:5278.